Astrocytes play a critical role in regulating the interface between the cerebral vasculature and the central nervous system. Contributing to this is the astrocytic endfoot domain, a specialized structure that ensheathes the entirety of the vasculature and mediates signaling between endothelial cells, pericytes, and neurons. The astrocytic endfoot has been implicated as a critical element of the glymphatic pathway, and changes in protein expression profiles in this cellular domain are linked to Alzheimer's disease pathology. Despite this, basic physiological properties of this structure remain poorly understood including the developmental timing of its formation, and the protein components that localize there to mediate its functions. Here we use human transcriptome data from male and female subjects across several developmental stages and brain regions to characterize the gene expression profile of the dystrophin-associated complex (DAC), a known structural component of the astrocytic endfoot that supports perivascular localization of the astroglial water channel aquaporin-4. Transcriptomic profiling is also used to define genes exhibiting parallel expression profiles to DAC elements, generating a pool of candidate genes that encode gene products that may contribute to the physiological function of the perivascular astrocytic endfoot domain. We found that several genes encoding transporter proteins are transcriptionally associated with DAC genes.
ture of astrocytes is the perivascular endfoot domain, which completely ensheathes the brain microcirculation (Mathiisen, Lehre, Danbolt, & Ottersen, 2010; McCaslin, Chen, Radosevich, Cauli, & Hillman, 2011) . This structure represents a secondary barrier, restricting the movement of cells and macromolecules from the abluminal face of the BBB into the wider parenchyma (Agrawal et al., 2006; Engelhardt & Coisne, 2011) . Though these anatomical features are well defined, little is known regarding the molecular composition of perivascular astroglial endfeet or the biophysical basis of their function. Here we use a human developmental transcriptomic database to gain insight into the developmental timing of endfoot protein expression. Gene network analysis is used to identify novel gene products that may be involved in perivascular endfoot function.
A distinctive feature of perivascular astrocytic endfoot processes is the presence of dense macromolecular arrays. These arrays are thought to be made up largely of the astroglial water channel aquaporin-4 (AQP4) (Dermietzel, 1973; Nielsen et al., 1997; Rash, Yasumura, Hudson, Agre, & Nielsen, 1998; Verbavatz, Ma, Gobin, & Verkman, 1997 ).
Yet, the physiological relevance of these formations is still not well understood. One possible function is in the recently described "glymphatic" system, a perivascular network that supports interstitial solute clearance through a process that is dependent upon astroglial water transport (Iliff et al., 2012; Xie et al., 2013) . Along this pathway, cerebrospinal fluid (CSF) and interstitial fluid (ISF) exchange across the perivascular astrocytic endfoot in an AQP4-dependent manner (Iliff et al., 2012 (Iliff et al., , 2014 . While the dense AQP4 arrays provide a low-resistance path for water diffusion, it remains unclear what cellular processes facilitate the rapid exchange of solutes along the perivascular compartment.
A critical component of the perivascular astrocytic endfoot domain is the dystrophin-associated complex (DAC). This multiprotein scaffolding complex maintains endfoot stability by intracellular interactions with astrocytic cytoskeletal components and by binding extracellularly with elements of the basal lamina (Boulay et al., 2015; Lunde et al., 2015) .
Known protein constituents of the DAC include dystroglycan, dystrophin, dystrobrevin, and a-syntrophin. The perivascular localization of AQP4 is maintained through its association with the DAC, as elimination of several DAC components including dystrophin and a-syntrophin, or extracellular binding partners such as agrin, disrupt perivascular AQP4 localization and endfoot integrity (Bragg, Amiry-Moghaddam, Ottersen, Adams, & Froehner, 2006; Bragg, Das, & Froehner, 2010; Derouiche et al., 2012; Nico et al., 2003; Noell et al., 2007 Noell et al., , 2011 . In the present study, we first characterize the developmental profile of DAC component expression across human brain regions to define the temporal profile of astrocytic endfoot development. Expanding upon this analysis, an unbiased bioinformatics approach is used to identify candidate genes exhibiting similar regional and developmental expression profiles to genes of the DAC complex.
| M A TE RI A L S A ND M E TH ODS

| Data sources
Links to access all of the data used for this study, including the Allen Brain Institute data and the Barres Brain RNA-seq data, are available in the "Data Accessibility" section.
| Allen Brain Institute Developing Human Brain Database
The data used for analysis came from the Allen Brain Institute Developing Human Brain Database (BrainSpan, 2010; Miller et al., 2014) . These data contained RNA-seq-based transcriptome data from 42 individuals ranging in age from 7 postconception weeks to 40 years. Sex of the individuals was balanced approximately evenly (19 females, 23 males).
RNA-seq data were collected from 16 brain regions within each individual, with over 20,000 genes read from each region, with the exception of tissue collected at the earliest prenatal stage (8-9 postconception weeks), at which larger regional dissections were made (10 total regions). Detailed description of tissue collection and processing is available in the documentation associated with the database (http:// help.brain-map.org//display/devhumanbrain/Documentation). Data were downloaded on October 24, 2016. Entrez IDs (as provided by Allen Brain Institute) were used for protein identification and subsequent analysis.
| Weighted Gene Correlation Network Analysis
Weighted Gene Correlation Network Analysis (WGCNA) was implemented using the WGCNA package in R (http://www.genetics.ucla.edu/ labs/horvath/CoexpressionNetwork/, RRID: SCR_003302) (Langfelder & Horvath, 2008 , 2012 . Because of the lack of full male and female data sets for multiple ages, a single network was constructed for each brain region, of which there were 16 in total. In the high-threshold network construction, initial filtering was applied prior to the analysis to eliminate spurious genes that had fragments per kilobase per million (FPKM) values of less than 10 in 90% or more of total reads. This resulted in approximately 8,000 genes per brain region. For the second, less conservative WGCNA, this threshold was adjusted to FPKM values of less than 3 in 95% or more of total reads, resulting in approximately 16,000 genes per region. Following standard practices, soft thresholding was used to establish a connection weight between each gene pair across gender and age within each brain region (Zhang & Horvath, 2005) . Using this soft-thresholding power, a topographical overlap matrix was generated, and a dendrogram relating gene expression was derived. Leveraging the developed dendrogram, gene modules were generated using hierarchical clustering.
| Cluster-based analysis
The gene modules in which DAC genes were most highly expressed were extracted from each brain region's WGCNA-based clusters. In the high-threshold analysis, of the 16 brain regions analyzed, 2 (amygdaloid complex and cerebellar cortex) did not demonstrate clustering of DAC genes and were excluded from further consideration. In the lowthreshold analysis, all 16 regions exhibited clustering of at least 2 DAC genes. Genes with robust astrocytic expression were extracted by thresholding out genes with less than 50% of total expression derived from astrocytes. Cell-type expression values were derived from a separate cell-type RNA-seq transcriptome database, resulting in 50 to 100 astrocytic genes per cluster (Zhang et al., 2014) . Drawing on the SIMON ET AL. | 181 consistent joint clustering of DAC genes, Pearson correlation coefficient was used to identify additional genes highly coexpressed with DAC complex genes across subjects. First, a gene was only considered as coexpressing with DAC components after a conservative correlation of r > .65 (p < 1e
25
) was observed with at least two of the DAC genes.
Next, genes were only selected that demonstrated this significant correlation to the DAC genes AQP4, DTNA, SNTA1, or DAG1 in at least 11 of 14 brain regions.
| Gene ontology analysis
To explore protein functions overrepresented in the "endfootenriched" modules, gene ontology analysis was used. Gene ontology was performed using the limma package in R (http://bioinf.wehi.edu. au/limma; RRID: SCR_010943) (Ritchie et al., 2015) . Only human pathway information was probed, with a false discovery rate cutoff of .05.
Functions with a p value for overrepresentation of p < .001 were reported.
| Subcellular localization mapping
Localization and associated functions of identified proteins were determined through literature review and the CellWhere database (http:// cellwhere-myo.rhcloud.com) (Zhu et al., 2015) . The UniProt and Gene ontology functions were used to assess cell localization.
| R ESU L TS
| DAC genes are highly expressed in astrocytes
To examine the transcriptome profile of the astrocytic endfoot, we first defined a set of "candidate endfoot genes" that encode proteins associated with the established roles of the DAC in perivascular endfoot physiology. This included five genes-four of which encode known DAC complex proteins: SNTA1 (alpha-syntrophin), DTNA (dystrobrevin), DMD (dystrophin), and DAG1 (dystroglycan)-as well as AQP4 ( Figure   1A ). Though histological analysis has suggested the presence of numerous proteins at the perivascular endfoot domain, genes encoding DAC proteins were chosen based on their function as a scaffolding complex and their integral role for endfoot stability (Bragg et al., 2006 (Bragg et al., , 2010 Nico et al., 2003; Noell et al., 2007 Noell et al., , 2011 . AQP4 interacts with the DAC complex, contributes to neurovascular and glymphatic pathway functions of the endfoot, and is thought to be a mediator of cell adhesion (Hiroaki et al., 2006; Iliff et al., 2012; Sun et al., 2016) . All five genes have been previously validated at the endfoot domain histologically. The developmental transcriptome data used to quantify expression of these genes were collected by regional microdissection of tissue, with no cell-type specificity. To ensure that information derived from these data is directly applicable to astrocytic endfeet and not influenced by Hierarchical branching of genes is described by the dendrogram (top); the colors correspond to the cluster to which each gene was assigned (bottom). (B) Relatedness between clusters generated by WGCNA analysis. Dendrogram demonstrating the relatedness between the clustered modules (top); the correlation between any two dendrograms is represented by the heat map (bottom).
developmental stages, expression of these DAC genes increases significantly during the late prenatal stages, whereas S100b does not increase until "Early Infancy" ( Figure 2G ). Results of statistical analysis of these data are available in Supplemental Table 1 . Although included in Figure   2 for visual reference, data from "Late Infancy" could not be subjected to statistical analysis because of insufficient sample size. These data suggest that the genes composing the DAC are not entirely transcriptionally linked and instead reflect two distinct transcriptional profiles.
| WGCNA reveals clustered expression of DAC genes
Prompted by the two temporally distinct DAC gene groupings, we next sought to probe the transcriptome database for novel candidate genes that might be transcriptionally linked to the DAC proteins. To cluster DAC expression patterns into broader gene expression groups within each brain region, WGCNA was performed to generate an unbiased, biologically motivated hierarchical clustering of genes across developmental age (Figure 3 , Supplemental Data Set 1). These clusters were probed for expression of the candidate endfoot proteins. For all brain regions examined, only two did not result in clustering of at least two of the candidate DAC proteins within a single cluster: amygdaloid complex and cerebellar cortex (Table 1 ). An endfoot-enriched cluster was defined as the cluster that included at least two of the five probe DAC genes. In the 14 regions that demonstrated endfoot gene clustering, AQP4 expression was present in all of the endfoot-enriched clusters.
DTNA and SNTA1 were each in 11 of the 14 endfoot-enriched clusters.
These results are indicative of highly correlated expression of three of the candidate DAC genes, AQP4, DTNA, and SNTA1, across most brain regions throughout development.
Although they did not consistently cluster with the other DAC candidate genes, we next sought to determine whether DMD and DAG1 display an independent co-clustering as suggested by the similarity of their temporal expression profiles ( Figure 2H ). Thresholding used in the initial WGCNA eliminated DMD from analysis because of a low expression level across samples ( Figure 1B ). To address this, a second WGCNA with a lower inclusion threshold was performed (Supplemental Data Set 2). In this analysis, DMD did not demonstrate co-clustering with other candidate endfoot genes in any of the 16 regions. DAG1 clustered with the other candidate genes in 4 of the 16 regions. With this reduced threshold, all three remaining candidate genes (AQP4, DTNA, and SNTA1) clustered together in 9 of the 16 regions, and at least two of the three clustered together in 14 of the 16 regions investigated. These data support the co-clustering of the 3 genes demonstrated in the original WGCNA and suggest that DMD and DAG1, despite similarities in temporal expression, are not linked transcriptionally.
| Identification of candidate genes transcriptionally associated with DAC-encoding genes
Using the gene pools generated by the WGCNA, we next aimed to identify candidate genes that may be coexpressed with DAC genes. An Acyl-CoA synthetase bubblegum family member 1
endfoot-enriched cluster gene list was collected for all 14 brain regions that exhibited co-clustering of candidate genes (Supplemental Table 2 ).
In total, 1,623 genes co-clustered with at least 1 DAC candidate gene in at least 1 region. The genes were then "ranked" based on a series of inclusion criteria to identify genes highly associated with the DAC candidate genes. The cluster gene list was generated based on the highthreshold WGCNA results, and thus associations with DMD were not assessed. Only genes that had a significant Pearson correlation coefficient with at least 2 of the 4 remaining DAC candidate genes in 11 or more of the 14 brain regions were analyzed further. The remaining genes were then assessed for astrocytic specificity based on the Barres Brain RNA-seq Database. These highly conservative criteria were used to offset the heterogeneity in the available data set. A list of 41 genes was generated (Table 2) . A literature review suggests that 13 of these gene products (Table 2 , gray) have previously been implicated histologically at the astrocytic endfoot compartment or brain perivascular space, while the remaining 28 genes encode novel endfoot candidate proteins. These data support the role of the previously defined proteins at the perivascular endfoot. The full list represents a transcriptionally linked unit that may be functionally connected at the endfoot domain.
| Characterization of gene product functions and developmental profiles for identified candidates reveals enrichment for transporter encoding genes
We next asked whether these transcriptional associations might reveal functional or structural units that are co-regulated at the gene expres- Table 3 .
| D I SCUSSION
In the present study, we investigated the human developmental expression profile of genes that encode proteins that contribute to perivascular astroglial endfoot function. We first defined the temporal expression profile of genes associated with DAC components and the water channel AQP4, which are known to localize to astrocytic endfeet and contribute to its function. Using the unbiased gene clustering technique WGCNA, we observed that DAC components, including most prominently AQP4, DTNA, and SNTA1, clustered in terms of their expression profiles across brain regions and throughout development.
Based on these clusters, we defined genes associated with DAC elements and AQP4 throughout the course of human brain development.
The genes identified by this analysis include both proteins that have been previously reported at the endfoot domain as well as entirely novel candidates. Our results suggest that components of the astrocytic endfoot complex may undergo concurrent upregulation during development. Furthermore, in addition to the water channel AQP4, components of the DAC may interact with, and be transcriptionally linked to, a number of ion and solute transporters.
Temporal analysis of DAC gene expression revealed two distinct profiles within the complex. While DMD and DAG1 demonstrate a 
Solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 -
FAM69C
Family with sequence similarity 69 member C, C18orf51
Note: List of the 5 endfoot candidate genes used, along with literature demonstrating localization at the astrocytic endfoot domain. Below, the list of 41 genes derived from the correlation analysis of genes in the "endfoot-associated" WGCNA clusters across brain regions, with any published literature regarding their known localization to the astrocytic endfoot domain. Genes in the gray section have been previously described to encode gene products found at the endfoot domain, while those in white have not been validated.
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| 187 consistent level of expression across development and aging, expression of the other three components (AQP4, DTNA, and SNTA1) undergoes significant age-linked fluctuation. These data suggest that the DAC complex is not transcriptionally linked as a whole but, rather, that it is regulated through two or more transcriptional modules. DMD and DAG1 have been suggested to directly interact with cytoskeletal and extracellular matrix components, respectively (Gesemann, Brancaccio, Schumacher, & Ruegg, 1998; Michalak & Opas, 1997; Szabo, Jancsik, Mornet, & Kalman, 2004) . These proteins may represent the "core" of the DAC complex that facilitate its membrane localization properties.
Complementary to this, SNTA1 and DTNA express multiple protein binding domains (Constantin, 2014) and may serve as interchangeable scaffolding components of the DAC that link the core to functional units such as signaling and transporter proteins. Further investigation is necessary to determine whether the apparent transcriptional coregulation of DAC proteins facilitates functional subdomains of the complex.
AQP4, DTNA, and SNTA1 demonstrate a significant elevation in expression beginning at the late prenatal stages (25-39 postconception weeks) and a slow decline in expression after early childhood (19 months to 5 years of age). This rise and fall in expression exhibits key differences from expression of the general astrocytic gene S100b. It is worth noting that recent studies suggest that astrocytes are a highly heterogeneous cell type, and it is possible that the expression profile of DAC genes may be consistent with an astrocytic subtype not enriched for S100b (John Lin et al., 2017) . The greatest differences from S100b expression are seen both in late prenatal development and in the aging brain. Elevated expression of these genes at the earliest stages of astrogliogenesis may reflect a role of astrocytes in distributing secreted factors critical to developmental processes such as BBB maintenance and neuronal maturation (Blanchette & Daneman, 2015; Chau et al., 2015; Gato et al., 2014; Lehtinen et al., 2011) . In the aging brain, the decline in expression of these proteins may help explain age-dependent changes seen in the localization of AQP4 to the endfoot domain (Zeppenfeld et al., 2017) .
With its unique location at the neurovascular interface, the endfoot is also critical to generation and maintenance of fluid and ionic homeostasis in the brain. Previous research in rats has shown that total water content in the brain decreases postnatally, and similarly the total brain amount of key ions Na (Lehmenkuhler, Sykova, Svoboda, Zilles, & Nicholson, 1993; Sykova, 2005; Vorisek & Sykova, 1997) . Accordingly, several DAC proteins found at the astrocytic endfoot, including AQP4, have been shown to markedly increase expression during the first 2 weeks of postnatal development in rodents, suggesting a role for these proteins in regulating developmental changes in extracellular volume and ion homeostasis (Lunde et al., 2015; Wen et al., 1999) . This notion is supported by the observation of increased total brain water with Aqp4 gene deletion (Nagelhus & Ottersen, 2013) . The decline in expression of these proteins with aging also has implications for our understanding of fluid and solute movement systems in the pathophysiology of the aging brain. Note: Molecular functions identified by GO analysis as enriched within the list of genes highly correlated to the DAC candidate genes (p < .00001). All functions are related to transporter functions, and produced a list of 11 total genes.
Since the initial description of the glymphatic system, the cellular basis of solute movement through the brain and the associated driving forces have remained poorly understood. While the initial characterization of glymphatic function suggested that arterial pulsation drives convective movement of CSF through the brain interstitial space (Iliff et al., 2012 (Iliff et al., , 2013 ), more recent computational modeling studies have suggested that these forces may be insufficient to drive bulk flow through these spaces under physiological conditions (Jin, Smith, & Verkman, 2016; Smith, Jin, & Verkman, 2015) . Most recently, intracellular flow and dispersion models have been elaborated as potential alternative mechanisms to explain the rapid exchange of solutes between the CSF and the ISF along perivascular pathways (Asgari, de Zelicourt, & Kurtcuoglu, 2015 , 2016 . Together, these illustrate the need for a more thorough understanding of the constituents of the astrocytic endfoot that may contribute to fluid and solute movement across this domain. The identification of several transporter genes transcriptionally linked to expression of DAC genes has major implications and may provide valuable insight into the mechanisms that facilitate fluid movement as described in the glymphatic pathway.
Among the identified transporters are components of the connexin complex GJA1 (encoding connexin 43) and GJB6 (encoding connexin 30). These gap junction proteins are astrocyte specific and play a role in maintenance of the interconnectivity of the astrocytic syncytium (Giaume, Koulakoff, Roux, Holcman, & Rouach, 2010) . Interestingly, both connexin 43 and connexin 30 have been observed at the astrocytic endfoot (Boulay et al., 2015; Nagy, Patel, Ochalski, & Stelmack, 1999; Simard, Arcuino, Takano, Liu, & Nedergaard, 2003) , and connexin 43 has been suggested to functionally couple endfeet domains. There are several limitations to our study. Primary among these is the data set on which our analysis was performed as many of the time points had small sample sizes. This is demonstrated by the "Late Infancy" developmental stage, from which only two samples were available. Furthermore, many of these did not have adequate coverage between genders. As previously noted, an additional drawback for our characterization is that the RNA-seq data used are not astrocyte specific and, instead, encompass genes expressed in all brain cell types. To diminish these effects and generate a conservative candidate gene list, strict inclusion criteria were used; however, the thresholds used were arbitrarily defined. Finally, it is important to note that analysis was lim- In this study, our data have defined a transcriptionally linked DACassociated unit, along with new candidate genes for this region. If confirmed by biochemical studies, these proteins represent novel targets for understanding and therapeutically treating impaired waste clearance in the aging brain.
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